Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Patient Compliance: A Major Challenge for Ophthalmologists

According to the results of a recent LinkedIn survey conducted by our team, treating eye conditions can be a daunting task for medical professionals due to several challenges. Patient Compliance The survey asked attendees what their biggest challenge was when…

Top 5 Milestones in Ophthalmology History

In this article, we explore five significant milestones in the history of ophthalmology that have shaped the way we approach eye health and treatment. The ancient Egyptians, known for their advanced civilization and remarkable contributions to various fields, including medicine,…

FDA Calls for Study on Aldeyra’s Reproxalap in DED

Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for reproxalap, an investigational drug candidate designed for the treatment of dry eye disease.…

Study Reveals Why People with Albinism Have Poor Vision

People with albinism often have poor vision. A new study from the Netherlands Institute for Neuroscience reveals the underlying cause. In Europe, albinism occurs in 1 in 20,000 individuals. However, in some populations, it is much more common, affecting 1…

Reviving Hope for Amblyopia: Late-Stage Treatment

In children with amblyopia, often referred to as “lazy eye,” one eye exhibits weaker vision than the other due to various factors. This weaker eye may struggle with focusing, misalignment due to strabismus, or vision obstruction from conditions like cataracts…

Scientists Innovate Tech for Ischemic Retinopathy Treatment

Professor Byoung Heon Kang and his research team at the Department of Biological Sciences at Ulsan National Institute of Science and Technology (UNIST), in collaboration with Professor Dong Ho Park’s team at Kyungpook National University Hospital, have developed a novel…

UCL-Moorfields Eye Hospital Secures £5M for Research Center

The Sir Jules Thorn Charitable Trust has allocated £5 million towards the establishment of a  research center within Oriel, the collaborative initiative between UCL and Moorfields Eye Hospital aimed at advancing eye health. Partnering with Moorfields Eye Charity and Moorfields…

Australian Government Funds $35M Cornea Facility

The Australian Government is making significant strides in the global fight against blindness by allocating funds for the establishment of a state-of-the-art manufacturing facility for artificial corneas. The University of Sydney has been designated to receive $35 million through the…

New Experimental Drug Shows Promise in Treating DME

A recent study published in Nature Medicine has unveiled promising insights into a potential breakthrough in the treatment of Diabetic Macular Edema (DME). The study suggests that an experimental drug, part of a new class of therapeutics called “senolytics,” could…

Stay informed and not overwhelmed, subscribe now!